• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Tata Chemicals Europe Invests Rs. 655 Crore in Sodium Bicarbonate

    INDPHARMAPOST

    Enforcement Report - Week of March 6, 2024

    FDA

    Enforcement Report - Week of January 24, 2024

    FDA

    Hospira, Inc. Issues A Voluntary Nationwide Recall For 4.2% Sodium Bicarbonate Injection, 8.4% Sodium Bicarbonate Injection, and Atropine Sulfate Injection Due to the Potential Presence of Glass Particulate Matter

    FDA

    Enforcement Report - Week of November 29, 2023

    FDA

    Enforcement Report - Week of November 15, 2023

    FDA

    Exela recalls 3 separate drugs over particulate concerns

    FIERCE PHARMA

    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL, and ELCYS (cysteine hydrochloride Injection), USP 500 mg/10 mL Due to the Presence of Particulate Matter

    FDA

    Hospira, Inc. Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP Due to the Potential for Presence of Glass Particulate Matter

    FDA

    Enforcement Report - Week of July 26, 2023

    FDA

    Omnivium`s Generic Sodium Bicarbonate Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of December 21, 2022

    FDA

    Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection

    FDA

    Enforcement Report - Week of November 2, 2022

    FDA

    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate Injection

    FDA

    US FDA grants approval for Azurity’s Konvomep to treat gastric ulcer

    PHARMACEUTICAL-TECHNOLOGY

    Enforcement Report - Week of June 8, 2022

    FDA

    Enforcement Report - Week of January 19, 2022

    FDA

    Enforcement Report - Week of January 5, 2022

    FDA

    Enforcement Report - Week of September 1, 2021

    FDA

    SterRx, LLC Issues Voluntary Nationwide Recall of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL

    FDA

    Civica signs supply agreement for medicine, after hospitals ration use

    IN-PHARMATECHNOLOGIST

    Civica Rx and Exela Pharma Sciences Join Forces

    PRESS RELEASE

    Enforcement Report - Week of August 14, 2019

    FDA

    Premier Pharmacy Labs Issues Voluntary Nationwide Recall of all Unexpired Sterile Drug Product Lots Due to Lack of Sterility Assurance

    FDA

    Enforcement Report - Week of May 1, 2019

    FDA

    Enforcement Report - Week of April 24, 2019

    FDA

    Enforcement Report - Week of April 10, 2019

    FDA

    Hospira, Inc. Issues a Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection

    FDA

    Enforcement Report - Week of January 16, 2019

    FDA

    Strides Pharma`s Generic Polyethylene Glycol 3350 & Electrolytes Receives in US

    FDA

    Enforcement Report - Week of July 18, 2018

    FDA

    Zydus Pharm`s Generic Omeprazole : Sodium Bicarbonate Receives Approval In US

    FDA

    Intl Medication’s Generic Sodium Bicarbonate Receives Approval In US

    FDA

    Enforcement Report - Week of September 20, 2017

    FDA

    Bella Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of All Sterile Drug Products

    FDA

    Enforcement Report - Week of August 16, 2017

    FDA

    Enforcement Report - Week of August 9, 2017

    FDA

    Hospira recall of vials adds to woes of sodium bicarbonate shortage

    FIERCE PHARMA

    Pfizer Canada Inc. Recalls Epipen Jr Due to Malfunction of The Affected Lots` Auto-Injector Sodium Bicarbonate Inj 8.4%

    HEALTH CANADA

    Hospira Issues a Voluntary Nationwide Recall For Sodium Bicarbonate, Succinylcholine Chloride, Potassium Phosphate Injections

    FDA

    Sodium bicarbonate one of 8 Pfizer drugs in short supply

    FIERCE PHARMA

    Enforcement Report - Week of March 22, 2017

    FDA

    Hospira Inc Generic Sodium Bicarbonate Receives Approval In US

    FDA

    Anvisa Suspended Lot Of 8.4% Sodium Bicarbonate From Samtec

    ANVISA

    Sciegen`s Generic Omeprazole; Sodium Bicarbonate Recevies Approval In US

    FDA

    Dr Reddy`s launches generic acid reflux drug in US

    ECONOMIC TIMES

    Ajanta Pharma launches acid reflux drug in US

    ECONOMIC TIMES

    Perrigo Announces FDA Final Approval And Launch Of The Store Brand Equivalent

    PR NEWSWIRE

    Dr Reddy`s Receives FDA Nod For Acid Reflux Drug Omeprazole & Sodium Bicarbonate

    FDA

    Actavis Receives FDA Nod For Acid Reflux Drug Omeprazole & Sodium Bicarbonate

    FDA

    Ajanta Pharma`s acid reflux drug approved in US

    FDA

    US FDA Enforcement Report- 1/June/2016

    FDA

    Formulation Of Venlafaxine Hcl As Gastro-Retentive Tablet

    PHARMA-EXCIPIENTS

    Hospira Issues a Voluntary Recall for One Lot of Sodium Bicarbonate Injection, USP Due to the Presence of a Particulate

    FDA

    Hospira Inc`s Generic Sodium Bicarbonate approved in US as an antacid

    FDA

    Granules to market Par Pharma`s generic heartburn drug in the US

    BUSINESS STANDARD

    NaturaLyte Sodium Bicarbonate Liquid Concentrate - Possible Bacterial Contamination

    HEALTHY CANADIANS

    Recall: Naturalyte Sodium Bicarbonate Liquid Concentrate (2015-05-06)

    HEALTHY CANADIANS

    Strides Arcolab gets USFDA nod for bowel-cleansing medicine

    THE ECONOMIC TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.